An increasing number of surgical treatments are performed for orthopedic pathologies in pets. Procedures such as arthrodesis or Tibial Tuberosity Advancement (TTA) have become reference treatments in cases of fractures or rupture of the cranial cruciate ligament (CCLD). Bone grafts, synthetic bone substitutes or metallic implants are often associated with these surgeries in order to improve bone repair and fusion but have various limitations in terms of availability, pain and risk of infection.
Thanks to its properties, BIOCERA-VET ideally meets the characteristics expected by veterinarians in order to limit pain and the risks of infection and to promote bone repair and consolidation.
The clinical indications of BIOCERA-VET - BONE SURGERY - are:
TTA (Tibial Tuberosity Advancement)
All indications for which bonegrafts are required
Osteosarcoma is a primary tumor of the bone that is the most common cancer in dogs and cats. Amputation of the affected limb is the treatment of choice, but it is not always possible (weakened animals, overweight, having already undergone an amputation, ...). Conservative therapy consisting in the removal of the tumor bone segment while maintaining limb function can be performed. Like amputation, this technique does not prevent cancer development and is often combined with chemotherapy in order to improve the quality of life and prolong the survival of the animal.
BIOCERA-VET provides an alternative of choice to amputation and to conservative treatment. Indeed, the injection of BIOCERA-VET into the bone cavity is intended to limit the pain, to reduce the risk of pathological fracture by reinforcing the structural strength of the affected bone tissue and improving mechanical support.